207 related articles for article (PubMed ID: 35307010)
1. Anti-PD-L1 monoclonal antibody for the management of chronic disseminated intravascular coagulation secondary to a urothelial carcinoma: a case report.
Maiorano S; Gulden-Sala W; Gerber B; Ghilardi G
J Med Case Rep; 2022 Mar; 16(1):113. PubMed ID: 35307010
[TBL] [Abstract][Full Text] [Related]
2. Successful chemotherapy management of disseminated intravascular coagulation presenting with metastatic clear cell renal carcinoma: a case report and review of the literature.
Le Trinh H; Nguyen VT; Mai NK; Tran BT; Pham QN
J Med Case Rep; 2020 Apr; 14(1):52. PubMed ID: 32312316
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation complicating urothelial malignancy.
Chadachan VM; Lee SK
Singapore Med J; 2012 Aug; 53(8):e161-2. PubMed ID: 22941143
[TBL] [Abstract][Full Text] [Related]
4. Resolution of thrombocytopenia secondary to disseminated intravascular coagulation with docetaxel chemotherapy in prostate cancer.
Talebi TN; Manoharan M; Singal R
Am J Ther; 2012 Jan; 19(1):e59-61. PubMed ID: 20535002
[TBL] [Abstract][Full Text] [Related]
5. Management of cancer-associated disseminated intravascular coagulation.
Levi M
Thromb Res; 2016 Apr; 140 Suppl 1():S66-70. PubMed ID: 27067981
[TBL] [Abstract][Full Text] [Related]
6. Hematologic Emergencies in the Postoperative Neurointensive Care Unit Setting: Illustrative Case Series and Differential Diagnosis.
Shaikh RHA; Akinduro OO; Hasan TF; Lee SJ; Ayala E; Quinones-Hinojosa AE; Cushenbery KA; Hammack JE; Yoon JW; Dickson DW; Freeman WD
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106019. PubMed ID: 34359018
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
8. Severe disseminated coagulopathy caused by adenocarcinoma with bone marrow metastasis.
Klenner AF; Greinacher A; Kuvikova A; Dölken G; Busemann C
Onkologie; 2013; 36(5):292-4. PubMed ID: 23689225
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC).
Kitchens CS
Hematology Am Soc Hematol Educ Program; 2009; ():240-6. PubMed ID: 20008204
[TBL] [Abstract][Full Text] [Related]
10. The use of ketoconazole in the emergency management of disseminated intravascular coagulation due to metastatic prostatic cancer.
Lowe FC; Somers WJ
J Urol; 1987 May; 137(5):1000-2. PubMed ID: 3573156
[TBL] [Abstract][Full Text] [Related]
11. Atezolizumab in invasive and metastatic urothelial carcinoma.
Crist M; Balar A
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1295-1301. PubMed ID: 28994323
[TBL] [Abstract][Full Text] [Related]
12. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
Tempelhof MW; Benzuly KH; Fintel D; Krichavsky MZ
Tex Heart Inst J; 2012; 39(1):86-91. PubMed ID: 22412237
[TBL] [Abstract][Full Text] [Related]
13. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
Wisecarver JL; Haire WD
Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
[TBL] [Abstract][Full Text] [Related]
14. Current drug treatment strategies for disseminated intravascular coagulation.
de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
[TBL] [Abstract][Full Text] [Related]
15. Acute onset of coagulopathy in a patient with Kasabach-Merritt syndrome following transurethral resection of bladder tumor.
Shoji N; Nakada T; Sugano O; Suzuki H; Sasagawa I
Urol Int; 1998; 61(2):115-8. PubMed ID: 9873252
[TBL] [Abstract][Full Text] [Related]
16. How I treat disseminated intravascular coagulation.
Levi M; Scully M
Blood; 2018 Feb; 131(8):845-854. PubMed ID: 29255070
[TBL] [Abstract][Full Text] [Related]
17. [Prostate cancer and disseminated intravascular coagulation: review of the literature].
Chargari C; Vedrine L; Bauduceau O; Le Moulec S; Fayolle M; Ceccaldi B; Houlgatte A
Prog Urol; 2008 Jan; 18(1):9-13. PubMed ID: 18342149
[TBL] [Abstract][Full Text] [Related]
18. [Overt disseminated intravascular coagulation complicating a venous malformation].
Zenati N; Seinturier C; Blaise S
Rev Med Interne; 2021 Feb; 42(2):131-133. PubMed ID: 33168353
[TBL] [Abstract][Full Text] [Related]
19. Durvalumab for the treatment of urothelial carcinoma.
Alsharedi M; Srivastava R; Elmsherghi N
Drugs Today (Barc); 2017 Dec; 53(12):647-652. PubMed ID: 29517083
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.
Levi M
Thromb Res; 2018 Apr; 164 Suppl 1():S77-S81. PubMed ID: 29703488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
